UPDATE 2-Sanofi bets on inhaled insulin with MannKind deal

* MannKind gets $150 mln upfront, up to $775 mln in milestones
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.